Asthma Management with Symbicort

Clinical Guidelines and Recommendations

• The National Asthma Education and Prevention Program (NAEPP) guidelines position ICS-LABA combinations like Symbicort at Step 3 and higher for asthma management, with LABAs being the preferred adjunctive therapy to combine with ICS in patients ≥12 years 1
• The American Academy of Allergy, Asthma, and Immunology recommends that LABAs should never be used as monotherapy for asthma, as stated in the Journal of Allergy and Clinical Immunology 2, 1

Treatment Efficacy and Safety

• No cited facts are available for this section, as the relevant information in the article is marked as [ignore ref]